 CAMBRIDGE, Mass., May 20, 2021 GLOBE NEWSWIRE -- Checkmate Pharmaceuticals Inc. NASDAQ: CMPI Checkmate, a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the Jefferies Virtual Healthcare Conference from 2:00-2:25pm ET on Tuesday, June 1, 2021. Checkmate will also host 1x1 investor meetings during the conference. 